肝栓塞联合大分割放射治疗原发性肝癌的价值

The Value of Hepatic Embolization Combined With Large Fraction Radiotherapy in the Treatment of Primary Hepatocellular Carcinoma

目的分析肝动脉栓塞化疗联合大分割放射治疗原发性肝癌的应用价值,评定临床研究价值。方法选取我院2016年11月—2017年10月收治的原发性肝癌患者68例作为研究对象。根据入院单双号的原则,将其随机分为两组,予以肝动脉栓塞化疗联合大分割放射治疗的34例患者为研究组,予以单纯肝动脉栓塞化疗的34例患者为参照组,最后对治疗效果的差异性进行总结。结果对比两组患者的治疗总有效率,研究组(88.23%)高于参照组(67.65%),两组比较,差异具有统计学意义(χ^2=4.191 2,P < 0.05)。结论原发性肝癌应用肝动脉栓塞化疗联合大分割放射治疗可获取显著的近期疗效。

Objective To analyze the value of transcatheter arterial chemoembolization combined with fractionation radiotherapy for primary liver cancer. Methods 68 patients with primary liver cancer admitted to our hospital from November 2016 to October 2017 were selected as the study subjects. According to the principle of single and double admission numbers, they were randomly divided into two groups. 34 patients were treated with transcatheter arterial chemoembolization combined with large fraction radiotherapy. 34 patients who received simple hepatic artery embolization and chemotherapy were the control group. Finally, the difference of therapeutic effect is summarized. Results Comparing the total effective rate of the two groups, the study group (88.24%) was higher than the reference group (67.65%). There was a significant difference between the two groups (χ^2=4.191 2, P<0.05). Conclusion Hepatic arterial chemoembolization combined with large fraction radiotherapy for primary hepatocellular carcinoma can achieve significant short-term efficacy.